Literature DB >> 406347

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

S B Halstead, E J O'Rourke.   

Abstract

Cultured mononuclear peripheral blood leukocytes (PBL) from nonimmune human beings and monkeys are nonpermissive to dengue 2 virus (D2V) infection at multiplicities of infection of 0.001-0.1, but become permissive when non-neutralizing dengue antibody is added to medium. D2V infection occurred in PBL prepared from anti-coagulated but not from defibrinated plasma. Infection enhancement was produced by multiple lots of heterotypic anti-dengue raised in several mammalian species. Homotypic anti-dengue neutralized D2V at high concentrations but enhanced at low concentrations; enhancement end point in one serum was 1:320,000. The infection-enhancing factor was a noncytophilic antibody of the IgG class. D2V infection occurred in the absence of heat-labile complement components but did not occur when complexes were prepared with anti- dengue F(ab)(2). Treatment of PBL with several proteases increased permissiveness to D2V infection by immune complexes but not by virus alone. Two rhesus monkey serums collected 14 days after D2V infection contained an IgG antibody with high-titered enhancing activity but with no hemagglutination-inhibition or neutralizing activity. Virus-antibody complexes are irreversibly attached to PBL within 15 min and completely internalized in 60 min. There was considerable variation in cellular infection in different experiments, however, maximum virus yields usually exceeded 1,000 plaque-forming units per 1 x 10(6) PBL occurring between 2 and 4 days in culture. In vitro antibody-dependent infection of PBL provides a possible model for study of pathogenetic mechanisms in infants with dengue shock syndrome who passively acquire maternal anti-dengue IgG.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406347      PMCID: PMC2180729          DOI: 10.1084/jem.146.1.201

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  Immunological enhancement of dengue virus replication.

Authors:  S B Halstead; J S Chow; N J Marchette
Journal:  Nat New Biol       Date:  1973-05-02

4.  Research on dengue during World War II.

Authors:  A B SABIN
Journal:  Am J Trop Med Hyg       Date:  1952-01       Impact factor: 2.345

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Effects of activated complement components on enzyme secretion by macrophages.

Authors:  H U Schorlemmer; A C Allison
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

7.  A simple micro-culture method for the study of group B arboviruses.

Authors:  A T De Madrid; J S Porterfield
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

8.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

9.  Shock syndrome in primary dengue infections.

Authors:  R M Scott; S Nimmannitya; W H Bancroft; P Mansuwan
Journal:  Am J Trop Med Hyg       Date:  1976-11       Impact factor: 2.345

10.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.

Authors:  S B Halstead; E J O'Rourke; A C Allison
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  297 in total

1.  Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys.

Authors:  N M Ferguson; C A Donnelly; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.

Authors:  W E Brandt; J M McCown; F H Top; W H Bancroft; P K Russell
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

5.  Determining the phagocytic activity of clinical antibody samples.

Authors:  Elizabeth G McAndrew; Anne-Sophie Dugast; Anna F Licht; Justin R Eusebio; Galit Alter; Margaret E Ackerman
Journal:  J Vis Exp       Date:  2011-11-30       Impact factor: 1.355

6.  Antibody-enhanced pneumococcal adherence requires IgA1 protease.

Authors:  Jeffrey N Weiser; Deborah Bae; Claudine Fasching; Ronald W Scamurra; Adam J Ratner; Edward N Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

7.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

9.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.

Authors:  J F Bukowski; I Kurane; C J Lai; M Bray; B Falgout; F A Ennis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  A mouse monoclonal antibody against dengue virus type 1 Mochizuki strain targeting envelope protein domain II and displaying strongly neutralizing but not enhancing activity.

Authors:  Atsushi Yamanaka; Tomohiro Kotaki; Eiji Konishi
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.